CSL (CSLLY) Stock Price, Quote, News & History

CSL Ltd (CSLLY) Stock Price, Quote, News & History

CSLLYOTCQX

Trade with Public

$25.09

0.451.81%

Last update: Apr 8, 9:38 AM

Key Statistics

Open

$25.09

Volume / Avg.

209.00 / 417.86K

Day Range

$25.09 - $25.09

52 Wk Range

22.83 - 44.86

Market Cap

$48.71B

P/E Ratio

15.98

Dividend Yield

2.96%

Exchange

OTC

RSI

Short Interest

Days to Cover

Recent CSL Ltd News

Eli Lilly's Landmark Trial Shows Major Psoriasis-Obesity Breakthrough With Taltz-Zepbound Combo

Eli Lilly's latest trial results and new licensing agreement show promise in treating psoriasis, obesity, and kidney disease.

Vandana Singh

Ionis Pharma Wins FDA Nod For First RNA-Targeted Therapy For Rare Genetic Swelling Disorder

FDA approved Ionis' Dawnzera for hereditary angioedema, showing up to 87% attack reduction and strong results in switch patients.

Vandana Singh

uniQure/ CSL Behring's Hemophilia Gene Therapy Shows Sustained Efficacy and Safety At Four Years

CSL and uniQure's Hemgenix shows sustained efficacy in hemophilia B, reducing bleeding rates by 90% and eliminating prophylaxis need for most patients at year four.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

Investing Cash Flow (TTM)

-850.00M

Financing Cash Flow (TTM)

-2.24B

Free Cash Flow (TTM)

2.54B

Capital Expenditure (TTM)

-1.02B

Net Change in Cash (TTM)

470.00M

Valuation Metrics

Enterprise Value

$56.87B

PE Ratio (TTM)

15.98

PE Ratio (FWD)

19.49

PEG Ratio (TTM)

PS Ratio (TTM)

3.11

PB Ratio (TTM)

2.56

Earnings Yield % (TTM)

6.26%

Earnings Yield % (FWD)

5.13%

EV / EBITDA (TTM)

11.08

Price / EBITDA (TTM)

9.34

Price / Free Cash Flow (TTM)

18.85

Book Value / Share

$9.61

Company Debt

Total Debt

$11.96B

LT Debt

$9.33B

LT Debt Issuance (TTM)

$97.00M

LT Debt Repayment (TTM)

-$832.00M

Total Cash

$1.52B

Debt to Equity

0.64

Issuance of Debt (TTM)

-$735.00M

Repayment of Debt (TTM)

-$832.00M

Key Statistics

Open

$25.09

Volume / Avg.

209.00 / 417.86K

Day Range

$25.09 - $25.09

52 Wk Range

22.83 - 44.86

Market Cap

$48.71B

P/E Ratio

15.98

Dividend Yield

2.96%

Exchange

OTC

RSI

Short Interest

Days to Cover

About

Sector

Health Care

Industry

Biotechnology

CSL is one of the largest global biotech companies and has three main segments. CSL Behring either uses plasma-derived proteins or recombinants to treat conditions including immunodeficiencies, bleeding disorders, and neurological indications. CSL Se...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

How do I buy CSL (CSLLY) stock?

You can purchase shares of CSL (OTCQX:CSLLY) through any online brokerage.

View our list of the best stock brokerages

Who are CSL (CSLLY) competitors?

There are no as such competitors for CSL.

What is the forecast, or price target, for CSL (CSLLY) stock?

There is no analysis for CSL to provide a consensus price target.

What is the current price for CSL (CSLLY)?

The stock price for CSL (OTCQX: CSLLY) is $25.092 last updated April 8, 2026 at 9:38 AM EDT.

Does CSL (CSLLY) pay a dividend?

There are no upcoming dividends for CSL.

When is CSL (OTCQX:CSLLY) reporting earnings?

CSL does not have any upcoming earnings scheduled.

Is CSL (CSLLY) going to split?

There is no upcoming split for CSL.

What sector and industry does CSL (CSLLY) operate in?

CSL is in the Health Care sector and Biotechnology industry. They are listed on the OTCQX.

Key Statistics

Open

$25.09

Volume / Avg.

209.00 / 417.86K

Day Range

$25.09 - $25.09

52 Wk Range

22.83 - 44.86

Market Cap

$48.71B

P/E Ratio

15.98

Dividend Yield

2.96%

Exchange

OTC

RSI

Short Interest

Days to Cover

Recent CSL Ltd News

Eli Lilly's Landmark Trial Shows Major Psoriasis-Obesity Breakthrough With Taltz-Zepbound Combo

Eli Lilly's latest trial results and new licensing agreement show promise in treating psoriasis, obesity, and kidney disease.

Vandana Singh

Ionis Pharma Wins FDA Nod For First RNA-Targeted Therapy For Rare Genetic Swelling Disorder

FDA approved Ionis' Dawnzera for hereditary angioedema, showing up to 87% attack reduction and strong results in switch patients.

Vandana Singh

uniQure/ CSL Behring's Hemophilia Gene Therapy Shows Sustained Efficacy and Safety At Four Years

CSL and uniQure's Hemgenix shows sustained efficacy in hemophilia B, reducing bleeding rates by 90% and eliminating prophylaxis need for most patients at year four.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

Investing Cash Flow (TTM)

-850.00M

Financing Cash Flow (TTM)

-2.24B

Free Cash Flow (TTM)

2.54B

Capital Expenditure (TTM)

-1.02B

Net Change in Cash (TTM)

470.00M

Valuation Metrics

Enterprise Value

$56.87B

PE Ratio (TTM)

15.98

PE Ratio (FWD)

19.49

PEG Ratio (TTM)

PS Ratio (TTM)

3.11

PB Ratio (TTM)

2.56

Earnings Yield % (TTM)

6.26%

Earnings Yield % (FWD)

5.13%

EV / EBITDA (TTM)

11.08

Price / EBITDA (TTM)

9.34

Price / Free Cash Flow (TTM)

18.85

Book Value / Share

$9.61

Company Debt

Total Debt

$11.96B

LT Debt

$9.33B

LT Debt Issuance (TTM)

$97.00M

LT Debt Repayment (TTM)

-$832.00M

Total Cash

$1.52B

Debt to Equity

0.64

Issuance of Debt (TTM)

-$735.00M

Repayment of Debt (TTM)

-$832.00M

Key Statistics

Open

$25.09

Volume / Avg.

209.00 / 417.86K

Day Range

$25.09 - $25.09

52 Wk Range

22.83 - 44.86

Market Cap

$48.71B

P/E Ratio

15.98

Dividend Yield

2.96%

Exchange

OTC

RSI

Short Interest

Days to Cover

About

Sector

Health Care

Industry

Biotechnology

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

How do I buy CSL (CSLLY) stock?

You can purchase shares of CSL (OTCQX:CSLLY) through any online brokerage.

View our list of the best stock brokerages

Who are CSL (CSLLY) competitors?

There are no as such competitors for CSL.

What is the forecast, or price target, for CSL (CSLLY) stock?

There is no analysis for CSL to provide a consensus price target.

What is the current price for CSL (CSLLY)?

The stock price for CSL (OTCQX: CSLLY) is $25.092 last updated April 8, 2026 at 9:38 AM EDT.

Does CSL (CSLLY) pay a dividend?

There are no upcoming dividends for CSL.

When is CSL (OTCQX:CSLLY) reporting earnings?

CSL does not have any upcoming earnings scheduled.

Is CSL (CSLLY) going to split?

There is no upcoming split for CSL.

What sector and industry does CSL (CSLLY) operate in?

CSL is in the Health Care sector and Biotechnology industry. They are listed on the OTCQX.